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Introduction
The most common problems in urogynecology, stress
urinary incontinence (SUI) and pelvic organ prolapse (POP)
are, in other words, problems of pelvic organ support. Ex-
tended demand for support in pelvic reconstructive surgery
has led to the development of both biomaterials and synthetic
grafts. The ideal biomaterial should be physically and
chemically inert, mechanically strong, noncarcinogenic, eas-
ily fabricated and stabilized, and should induce minimal in-
flammatory reaction 
1.
Experimental studies and mesh behavior
Several studies have analyzed biomaterials derived
from dermal, pericardial, dural, and other anatomical
sources, and have emphasized their non-uniform graft be-
havior, variable preparation, and unpredictable quality 
2.
Synthetic grafts clearly demonstrated superior durability and
long-term success over biomaterials for pelvic floor repair 
3.
The most widely accepted method of testing synthetic
grafts is through experimental animal studies. In analyzing
the literature, it is obvious that rats are the most commonly
accepted experimental model. Several study groups have set
the standard for methods as well as tissue analysis and tensile
strength in experimental studies 
4, 5. Primary repair of full-
thickness abdominal wall defect, with respect to the perito-
neum, seems like a logical choice. Monofilament polypro-
pylenes were theoretically and practically the first choice for
testing, considering the assumption that multifilaments are
prone to infection 
4. There is consensus that an average of
90-μm pore size provides the best mechanical anchorage,
with peak in-growth reached at around 400–500 μm 
1, 2.
Larger pores limit the deposition of collagen to the perifila-
ment region, with central parts being deposited with fat. A
solid product, as well as one with smaller pores (< 50 μm),
can lead to complete encapsulation or induce an intensive in-
flammatory reaction. In addition, the intensity of an inflam-
matory reaction is determined by the amount of synthetic
material, therefore suggesting the use of lighter materi-
als 
1, 4 6.
It is presumed that multifilaments with interfilamen-
tous spaces smaller than 10 μm are prone to infection,
bearing in mind that macrophages are 15 μm in diameter,
and bacteria 1–2 μm. Multifilaments were theoretically
supposed to have better elasticity, but the same results are
achieved with low weight monofilaments 
4, 5. After an ini-
tial polypropylene testing, some advances in biocompati-
bility were to be revealed experimentally on a polypropyl-
ene-coated field. Collagen-coated and titanium-coated
grafts were to express a less intensive inflammatory reac-
tion, with the same results, on a field of collagen deposi-
tion; however, they failed 
6. Arginine administration was
also evaluated in experimental models for improved mesh
integration, but the experimental data are inconclusive 
7.
Some rather interesting data were revealed on initial ex-
perimental analysis of semi-reabsorbable (polypropylene-
polyglactin) grafts 
6. Later studies determined that the
semi-reabsorbable combination proved to be a stable scaf-
fold for collagen deposition, leaving less foreign material
after polyglactin reabsorption, with no consequences on
tensile strength 
5. Experimental studies have revealed a to-
tally new perspective on the mechanical analysis of incor-
porated grafts. Tensiometric studies of native graft samples
have indicated significant differences in strength among
tested samples. When colonized by cells and incorporated
with native tissue, explanted samples provided comparable
tensiometric strength, regardless of the material used 
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Some studies even reported that stronger tensiometric re-
sults were achieved with monofilaments than with multi-
filaments 
4.
Experimental studies have suggested a high modality
and uniform quality of synthetic meshes, with a rather steady
retraction rate of about 20% 
1, 4, 5. Graft retraction seems to
correlate with stiffness parameters in the elastic domain of
graft deformation 
5. Retraction rates, when summarized,
highlight the well-known postulate of tension-free surgery.
Consensus on a cascade Worman’s effect is almost ab-
solute. Protein covering of the graft and inflammatory reac-
tion within the first three weeks are the initial steps of for-
eign body reaction 
1. The reparation process, regardless of
the experimental animal model, is characterized by collagen
deposition and final stabilization within six weeks 
4, 5.
One study even analyzed cell oxidative stress levels in
relation to the mesh material used 
5. Conclusions definitely
confirmed a positive correlation between cell oxidative stress
and the amount of implanted synthetic material. In summary,
rat studies have shown good biocompatibility, respectable
tensile strength, and fewer complications.
In several studies, rabbits were chosen as an experi-
mental model, but they showed no difference in graft be-
havior 
8. Pigs are less common, considering that large ani-
mals are not as easy to manipulate, and the experimental
samples are smaller. The highest level of retraction reported
in an experimental study on pigs is 30% 
9. However, this re-
sult should be considered cautiously, as retraction was meas-
ured with millimeter paper alone. One of the interesting, but
rare, experimental studies conducted on very large animals
included horses 
10. Fifteen horses were treated with polypro-
pylene meshes for large abdominal hernias and the results
were exceptional, except for one fatality.
In summary, future perspectives seem to favor semi-
reabsorbable, low-weight monofilament meshes, with totally
inert synthetic grafts being the ultimate theoretic goal.
Mesh in the treatment of stress urinary incontinence
Stress urinary incontinence is a highly prevalent (41%)
problem; 72% of patients have moderate to severe symp-
toms, with only 25% seeking professional help 
11. There is a
prognosis that requirements for surgery will increase up to
45% in the future, due to less tolerance of SUI symptoms by
patients and the normal aging of female population expected
in western countries 
12. Synthetic materials have been gener-
ally used in the treatment of SUI after wide acceptance of the
Petros and Ulmsten theory of continence 
13. The sling was
moved from the bladder neck to the midurethral position and
placed in a tension-free manner. The role of the sling is sup-
port of the urethra, instead of previous tension sutures placed
on the bladder neck or a fascial sling placed on the same po-
sition 
14, 15.
The sling is placed retropubically, transobturatory, or as
a mini (single incision) sling. Tension-free placement has
contributed to their non-obstructive behavior, low incidence
of urinary retention, no exaggeration of prolapse, and de-
creased deterioration of the posterior compartment 
16, 17.
Postoperative sexual dysfunction is infrequent, due to an un-
changed vaginal axis, which is the most frequently recog-
nized flaw of the Burch operation 
18, 19. Retropubic placement
of the sling requires cystoscopy as a mandatory part of the
procedure, and sling placement was limited in very obese
patients and in patients with previous pelvic surgery and sus-
picious intestinal adhesions. Transobturatory placement per-
formed “inside out” or “outside in” (both ways are almost
equal, with “inside out” being slightly superior) 
20, 21 became
an acceptable alternative that does not require cystoscopy
and does not affect the abdominal cavity. Mini slings are the
least invasive, placed in a U position or horizontally. There
were high expectations and hopes because of the convenient
pain profile, but the results were not as encouraging, and their
use is performed with caution 
22–24. There are also self-tailored
modifications or industrial modifications of the sling, which
are applied with similar or equal success rates 
25, 26.
However, no one way of sling placement is absolutely
complication free 
27, 28. This is especially important to keep
in mind, because the surgery is performed with the aim of
improving quality of life, and dangerous reported complica-
tions, such as bowel perforation and serious bleeding (the
majority after retropubic sling surgery), can compromise the
procedure seriously.
Success rate (effectiveness) is measured subjectively
(interviews, different questionnaires), objectively (e.g. 24-
hour pad test, stress test), or as a combined evaluation after
surgery. Subjectively evaluated success is always higher than
objectively measured one, and varies between 85.7% and
91.6%. The number of satisfied females with significant im-
provement is higher than the number of completely dry pa-
tients 
29.
Unfortunately, dryness is not the only outcome of the
surgery. Complication rates should not be neglected, but they
are usually underreported. The reported complication rate is
4.3–75.1% for retropubic and 10.5–31.3% for transobtura-
tory midurethral slings 
30. The most important predictive
factors for sling failure are documented intrinsic sphincter
deficiency (ISD) and fixed urethra. It is assumed, in other
words, that in patients with a fixed urethra, the main problem
is low resistance at the level of the bladder neck, and not
urethral support, so the support improvement achieved by the
sling is less likely to be curative. Fortunately, the results of
tension-free tape (TVT) and adjustable slings in these patients
are only a little inferior, or equal, to the results of TVT (66%
and 85% cured patients, respectively) 
30, 31. There is a docu-
mented follow-up of patients with suprapubic TVT–11.5 years
and transobturator tabe (TOT) – 6.5 years, without significant
differences between the procedures. Both of these procedures
have a stable, long-term success rate (77% and 83%, respec-
tively) 
32, 33. The difference was not spectacular compared with
the Burch Tangho operation (70% dry patients) 
34.
Recurrent SUI is not an uncommon problem after ten-
sion-free procedures. The success rate is lower than after
primary treatment (63.5% dry), but it is still acceptable.
There is scarce evidence of favorable types of slings for the
“redo” surgery, but the retropubic sling seems to be more ef-
fective than the transobturatory sling 
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Postoperative voiding dysfunction and urinary retention
after sling procedures are underreported. Frequency of uri-
nary retention (1.8–10%) is highest in patients with the ret-
ropubic sling, but it is not absent with the transobturatory or
single-incision sling. It is usually temporary, and intermittent
catheterization or catheter removal several days later solves
the problem. Long-term retention (15 days) usually requires
pulling down the sling or a sling section, or removal of the
sling. In the majority of cases, it does not result in the recur-
rence of SUI 
37–41.
There was a confusing terminology in previous years
regarding the complications-sling exposition and erosion. It
is accepted now that sling exposition describes a visible sling
in the vagina, uncovered by the vaginal epithelium. Sling
erosion is a penetration of the sling into the adjacent viscera.
The more frequent surgical complications of the sling is ex-
position (13%) 
41, 42. Sling exposition is usually expressed as
vaginal discharge, pain during intercourse, or sexual discom-
fort. Sometimes it occurs up to ten years after the sur-
gery 
42, 44. Sling erosion is the consequence of such condi-
tions as migration in the urinary bladder or urethra, or ab-
scess formation. In extreme cases, consequent vesicovaginal
or uterovaginal fistulas are possible 
45, 46. Possible explana-
tions for sling exposition are insufficient surgical skill,
structure of the sling material, or susceptibility of the ham-
mock to the sling 
42. Sexual function could be improved
(29.5% and 32.5% for TVT and TOT, respectively), deterio-
rated (17.3% and 12.5%), or unchanged after the sling pro-
cedures 
47. The vast majority of patients will have improve-
ment in their sexual life, but statements about postoperative
sexual function must be included in the informed consent be-
fore the surgery 
47–49.
Overactive bladder symptoms and mixed urinary in-
continence are not contraindications for the sling. Postopera-
tive urgency could start before the surgery and remain after
the surgery, or appear as a phenomenon de novo 
50, 51. Preop-
erative urgency is more frequent in patients; mixed urinary
incontinence, age, nocturia, maximum cystometric capacity,
and choice of sling procedure influence detrusor overactivity
and urge urinary incontinence 
52. In the majority of cases,
postoperative urgency is sensory and can be controlled with
anticholinergics. If urgency persists, removal of the sling is
mandatory 
53.
Mesh in the treatment of pelvic organ prolapse
Pelvic organ prolapse is a frequent disease among the
aging female population. Almost 11% of the female popu-
lation up to the age of 80 will require some type of surgical
correction of POP 
54. Generally, correction of POP is per-
formed with native tissue (NAT repair), mesh adjunct (pure
synthetic material, resorbable or not), or rarely, graft (bio-
logical material), is used to repair the pelvic floor. Correc-
tions are usually undertaken because of the anatomical dis-
order (vaginal bulge) and/or coexisting symptoms of pro-
lapse included in symptom/bothersome symptom question-
naires. Vaginal bulge is the most prominent symptom; oth-
ers include pelvic pressure, associated incontinence or uri-
nary retention and bowel emptying problems, and sexual
dysfunction.
Several major influences on POP surgery have been
recognized: extensive reports that some degree of prolapse is
not obviously symptomatic, changing criteria for performing
surgery, and differences in the evaluation of surgery out-
come.
Normal anatomic prolapse variations were well recog-
nized in a study of routine clinical examinations of asymp-
tomatic females, and it was confirmed that POP stage I is
present in 38%, and stage II in 35% of patients. If it is evalu-
ated as a result of surgery, more than 75% will not meet the
criteria for ideal, and 40% for satisfactory outcome 
55. To
mitigate a tendency to surgically “overcorrect” the anatomy
of asymptomatic females, the evaluation criteria have
changed. Acceptable results of successful repair are absent
prolapse beyond the hymen, no symptoms, and no need for
additional treatment 
56. Therefore, the main advantage of the
polypropylene mesh superior anatomical restoration of the
female genitalia was lost. In anterior vaginal repair, the effi-
ciency of mesh surgery was confirmed to be superior to that
of non-mesh surgery, which has a failure rate of 29% 
57. Ten
randomized control studies showed that synthetic absorbable
mesh has the highest failure rate (23%), followed by biologi-
cal graft (18%) and non-absorbable synthetic mesh (5%) 
57.
Safety was highest in cases with absorbable mesh (exposure
rate, 0.6%), followed by biological grafts (6%) and synthetic
non-absorbable mesh (10%) 
57. Posterior repair, with or
without mesh, is significantly less frequently reported, and
there is no confirmed evidence of a clear superiority of the
special method of posterior compartment repair 
58. Clinical
experience suggests that mesh will surely keep its place in
strict indications (mesh compared to non-mesh surgery: re-
current prolapse/success rate, 90.4% versus 54.8%, respec-
tively; paravaginal defect, 97.6% versus 65.6%; badly dam-
aged pelvic floor, 64% versus 22.9% 
59, 60. Symptoms after
mesh correction are based on clinical studies, and use of the
mesh was not proved in lower grade prolapse 
61. In other
words, restoring anatomy does not mean restoring symptoms
at the same time.
Apical defect, although less frequently discussed, is a
normal prerequisite for the success of POP surgery. It can be
performed with adequate success using a variety of surgical
options: vaginal sacrospinous support with mesh (tailored or
modified), or colposacral fixation performed by robotics,
laparoscopy, or open surgery 
62, 63. Safety of the mesh sur-
gery is lower, according to reported complications, some of
them dangerous or life threatening 
64, 65.
Sexual dysfunction increases constantly with age. The
frequency of sexual dysfunction is up to 50%, and it has a
multifactorial origin 
66. Surgeries of any type, as well as con-
comitant gynecological pathology, could deteriorate sexual
function without reliable data to address the source of sexual
dysfunction to the mesh directly 
67. However, the Food and
Drug Administration (FDA) has recently issued warnings re-
garding increased complications of mesh surgery and the ex-
aggerated justification for its use in clinical settings 
68, 69.
Almost no one could ignore these statements 
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Finally, all aspects of POP must be evaluated carefully:
anatomy, symptoms, quality of life, late complications, and
possible repeated surgeries 
69. We have to create a treatment
design to meet the criteria of the patients more comprehen-
sively, with native tissue repair whenever it is possible, and
with mesh only when it is absolutely necessary.
Conclusion
Synthetic materials have been developed constantly
during previous decades, but they have not achieved the
standards of ideal foreign material. Their biologic behavior is
still unknown, especially after long-term follow-up. Im-
provements in the treatment of stress urinary incontinence
are remarkable, and polypropylene slings have met the crite-
ria for the gold standard of treatment, both for the suprapubic
and transobturatory routes of application. It is not the same
for mini slings. Meshes in pelvic organ prolapse surgery are
superior for the correction of anatomy, but the overall benefit
of their use is not remarkable, and complications are more
frequent. It is certain that recent experiences will substan-
tially diminish the use of mesh in pelvic organ prolapse sur-
gery, as the restoration of anatomy is not a single goal of
surgery. However, its use will be kept for selected patients.
Improvement of our knowledge, both fundamental and clini-
cal, is necessary for superior pelvic organ prolapse repair.
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